摘要
To the Editor:Psoriatic arthritis(PsA)affects up to 30%of patients with psoriasis,contributing to a decreased quality of life.PsA can involve a variety of clinical manifestations,including peripheral and axial arthritis,enthesitis,dactylitis,and nail disease.[1]Early intervention is important for preventing loss of function and permanent disability;however,the diagnosis of PsA is often delayed by an average of five years.[1]Therefore,it is important to identify biomarkers that can detect PsA in patients with psoriasis.
基金
funded by the National Key Research and Development Program of China(No.2023YFC2508100)
the National Natural Science Foundation of China(Nos.81773322,82173420,81673054,81673073,and 81974471)
the Shanghai Municipal Commission of Health and Family Planning(No.2023ZZ02018)
the Shanghai Municipal Key Clinical Specialty(No.shslczdzk01002)
the Natural Science Foundation of Shanghai(No.20ZR1440100)
the Key Project in Basic Research Advocated by Shanghai Science and Technology Commission(No.13JC1402300)
the Clinical Research Plan of SHDC(Nos.SHDC2020CR6022,SHDC2020CR1014B,SHDC22022302,and SHDC2024CRI052).
